Disposable Plastic Blood Bag Sales

Disposable Plastic Blood Bag Sales Market Outlook

The global disposable plastic blood bag market is poised for remarkable growth, with a projected market size of USD 1.5 billion by 2035, growing at a CAGR of 6.5% from 2025 to 2035. The increasing demand for safe blood transfusion practices, coupled with innovations in blood bag manufacturing technology, is significantly contributing to market expansion. Furthermore, the rise in road accidents, natural disasters, and the prevalence of chronic diseases that necessitate blood transfusions are accelerating the demand for these disposable bags. Additionally, stringent regulations regarding blood safety and advancements in healthcare infrastructure are set to drive further growth in this sector. An ongoing emphasis on improving healthcare services in developing regions is also expected to foster an increase in blood donation, thereby boosting the demand for disposable plastic blood bags.

Growth Factor of the Market

The primary growth factor for the disposable plastic blood bag market stems from the increasing volume of blood donations and transfusions across the globe. Factors such as the surging prevalence of chronic illnesses, including cancer and liver diseases, require frequent blood transfusions, thereby driving demand for efficient blood storage solutions. Additionally, the expansion of healthcare facilities, particularly in emerging economies, enhances access to advanced medical technologies, subsequently increasing blood transfusion services. The rising awareness regarding blood safety and the importance of using sterile, single-use bags to prevent contamination is also prompting healthcare providers to opt for disposable plastic blood bags over traditional methods. Furthermore, innovations in the design and material used for these bags are improving their functionality, making them more appealing to medical institutions. Collectively, these elements create a robust environment for market growth in the coming years.

Key Highlights of the Market

• Projected market size of USD 1.5 billion by 2035, with a CAGR of 6.5%.
• Increased blood donation initiatives and regulations enhancing blood safety.
• Technological advancements in blood bag materials and manufacturing processes.
• Growth in healthcare infrastructure in developing regions supporting market demand.
• Rising prevalence of chronic diseases driving the need for blood transfusions.

By Product Type

Single Blood Bag:

Single blood bags are primarily utilized for the collection and storage of whole blood. These bags are designed to hold a single unit of blood and are essential in facilitating straightforward transfusion processes. The growing number of blood donation drives and a keen emphasis on efficient blood collection practices are propelling the demand for single blood bags. Furthermore, the rising incidence of surgeries, accidents, and trauma cases that require immediate access to blood are significantly contributing to the growth of this segment. In addition, advancements in manufacturing technology have led to improved bag durability and sterility, further enhancing their appeal among healthcare providers. The cost-effectiveness and ease of use associated with single blood bags make them a preferred choice in various medical settings.

Double Blood Bag:

Double blood bags are designed to separate red blood cells and plasma, offering a more versatile solution for blood component separation. This type of bag allows for more efficient blood storage, enabling healthcare professionals to utilize different blood components based on patient needs. The demand for double blood bags is increasing due to the rising emphasis on component therapy that allows for targeted treatment of various medical conditions. Moreover, the ability to collect, store, and transfuse multiple components from a single donation not only maximizes the use of available blood but also enhances patient outcomes. As healthcare facilities continue to adopt more complex treatment methodologies, the double blood bag segment is anticipated to experience significant growth in the coming years.

Triple Blood Bag:

Triple blood bags facilitate the collection of whole blood while also enabling the separation of red blood cells, plasma, and platelets. This versatility is particularly relevant in multi-component transfusion settings, where a single donation can cater to various patient requirements. The increasing prevalence of hematological disorders and the growing number of surgical procedures are propelling the demand for triple blood bags. Furthermore, hospitals and blood banks are focusing on enhancing their operational efficiency by optimizing blood utilization, thus fostering the adoption of triple blood bags. The segment is anticipated to witness sustained growth, driven by these evolving healthcare practices and the need for effective blood management systems.

Quadruple Blood Bag:

Quadruple blood bags offer an advanced solution for blood component separation, enabling the collection of four different components from a single donation. This design is particularly beneficial for blood banks that require a diverse range of blood products for transfusions and treatments. The increasing demand for blood components, especially platelets and plasma, is significantly driving the growth of the quadruple blood bag segment. Additionally, advancements in blood bag technology have improved the separation efficiency and storage conditions for each component, making these bags an integral part of blood transfusion therapies. As hospitals and clinics continue to emphasize personalized medicine, the quadruple blood bag is likely to experience heightened demand due to its comprehensive collection capabilities.

Penta Blood Bag:

Penta blood bags are a relatively newer innovation in the blood bag market, allowing for the collection and storage of five different blood components. This technology aligns with the increasing trend towards component therapy, where specific blood components are administered based on individual patient needs. The penta blood bag's design facilitates greater flexibility in blood storage and enhances the utilization of donated blood. While currently a niche market, the growth potential for penta blood bags is significant as more healthcare providers look for efficient solutions to manage blood resources amidst growing demand. The ongoing development in this area will likely contribute to an increase in the adoption of penta blood bags over time.

By Application

Blood Banks:

Blood banks are one of the primary users of disposable plastic blood bags, as they play a crucial role in the collection, testing, storage, and distribution of blood products. The increasing number of blood donation drives and the rising demand for safe blood transfusion practices are propelling the growth of disposable plastic blood bags in this segment. Blood banks require efficient systems to manage blood storage and to ensure the sterility of collected units. As the focus on blood safety intensifies, the demand for high-quality, disposable plastic blood bags that minimize contamination risks is expected to increase. Furthermore, the ongoing advancements in blood bag technology, including features like anti-coagulation and filtration systems, are likely to enhance operational efficiency within blood banks.

Hospitals:

Hospitals constitute a significant market for disposable plastic blood bags, as they are instrumental in providing immediate blood transfusions during surgeries, emergencies, and treatments for various medical conditions. The rising number of surgeries, trauma cases, and chronic illness treatments has escalated the need for blood transfusion services, consequently driving demand for disposable blood bags. Hospitals prioritize the use of single-use bags to ensure patient safety and reduce the risk of cross-contamination. Furthermore, hospitals are increasingly adopting advanced blood management systems that utilize efficient blood storage solutions, further bolstering the adoption of disposable plastic blood bags in their operations. As healthcare facilities continue to expand, the hospital segment is anticipated to maintain steady growth.

Clinics:

Clinics are emerging as an essential segment for disposable plastic blood bags, particularly as they expand their services to include outpatient procedures, minor surgeries, and emergency cases. The growing trend towards decentralized healthcare is encouraging clinics to adopt blood transfusion capabilities, resulting in increased demand for disposable blood bags. Clinics require versatile solutions that cater to various patient needs, which makes single and double blood bags particularly appealing. Furthermore, the emphasis on patient safety and quick access to blood products is driving clinics to adopt disposable blood bags that ensure sterility and ease of use. As clinics continue to enhance their service offerings, the adoption of disposable plastic blood bags is expected to rise significantly.

Others:

Other applications of disposable plastic blood bags may include research laboratories, veterinary clinics, and emergency medical services. In research settings, blood bags are often used for various studies related to blood components and transfusion practices. Veterinary clinics, particularly those that treat large animals, may also utilize these blood bags for transfusions. Emergency medical services require portable solutions for blood storage during transport, making disposable plastic blood bags a crucial component of their kits. As the versatility of these bags continues to gain recognition, the segment encompassing 'Others' is expected to expand, driven by the diverse range of applications beyond traditional healthcare settings.

By Distribution Channel

Online Stores:

Online stores are becoming increasingly popular as a distribution channel for disposable plastic blood bags, offering convenience and broader access to healthcare facilities. The growth of e-commerce has allowed blood banks, hospitals, and clinics to purchase medical supplies directly from suppliers with ease. This channel provides a variety of products at competitive prices, which is particularly beneficial for smaller healthcare facilities with budget constraints. Furthermore, the ability to compare products and read reviews enhances the purchasing decision for healthcare professionals. As online shopping continues to thrive, the market for disposable blood bags through this distribution channel is expected to grow, driven by convenience and accessibility.

Hospitals & Clinics:

Hospitals and clinics represent a traditional yet crucial distribution channel for disposable plastic blood bags. These institutions require a steady supply of blood bags to facilitate ongoing medical procedures and transfusion needs. The partnership between blood bag manufacturers and healthcare providers ensures that hospitals and clinics receive high-quality products tailored to their operational needs. Furthermore, hospitals and clinics often buy in bulk, fostering long-term supplier relationships that ensure timely deliveries and consistent product availability. As the demand for blood transfusions continues to rise, the collaboration between manufacturers and healthcare facilities will strengthen, propelling the growth of this distribution channel.

Blood Donation Centers:

Blood donation centers are integral to the supply chain of disposable plastic blood bags, as they are the primary sites for blood collection. These centers require a significant number of blood bags for each donation event, making them crucial customers for manufacturers. The increase in blood donation campaigns and community initiatives is driving the growth of this segment. Blood donation centers prioritize the use of safe and sterile bags to ensure the quality of the collected blood. As awareness of the importance of donating blood continues to rise, the demand for disposable plastic blood bags through this channel is likely to experience substantial growth.

Others:

The 'Others' category for distribution channels encompasses various alternative methods for supplying disposable plastic blood bags, including direct sales from manufacturers to healthcare facilities or third-party distributors catering to specialized needs. This channel may include regional suppliers and local distributors who focus on serving niche markets, such as smaller clinics or veterinary practices. Additionally, some manufacturers may engage directly with end-users in specific geographic areas to supply their products. As the healthcare landscape evolves and the demand for disposable blood bags continues to rise, the 'Others' distribution channel is expected to grow, allowing for greater flexibility and accessibility for healthcare providers.

By Material Type

PVC:

Polyvinyl chloride (PVC) is the most widely used material for disposable plastic blood bags due to its favorable properties such as flexibility, durability, and resistance to chemical degradation. PVC blood bags offer excellent transparency, allowing for easy monitoring of the blood content and any potential contamination. The affordability and availability of PVC make it a preferred choice among manufacturers. Additionally, advancements in PVC formulations have led to the development of bags that incorporate anti-coagulation features, enhancing blood storage capabilities. As the demand for affordable and reliable blood storage solutions continues to rise, PVC-based blood bags are expected to maintain a significant share in the market.

TPU:

Thermoplastic polyurethane (TPU) is gaining traction as a material for disposable plastic blood bags due to its superior flexibility and mechanical properties. TPU bags are known for their strength and resistance to punctures, thereby enhancing the safety of blood storage and transportation. Furthermore, TPU offers better barrier properties compared to PVC, which helps in maintaining the sterility of blood components for extended periods. As healthcare providers increasingly prioritize patient safety and quality in blood management, the demand for TPU-based blood bags is projected to grow steadily. The ability of TPU to be customized for specific applications further solidifies its position in the market.

PET:

Polyethylene terephthalate (PET) is recognized for its strength and chemical resistance, making it a viable alternative for disposable plastic blood bags. PET bags are lightweight and have excellent gas barrier properties, which help in preserving the integrity of the stored blood components. The use of PET is particularly advantageous in environments where weight is a concern, such as in mobile blood collection units. As the focus on environmentally friendly materials intensifies, the adoption of PET in the blood bag market is expected to grow, driven by its recyclable nature and sustainability appeal. This shift towards PET may also resonate with healthcare organizations aiming to improve their environmental footprint.

PE:

Polyethylene (PE) is another material used for disposable plastic blood bags, primarily in specific applications where flexibility and cost-effectiveness are paramount. PE bags offer good puncture resistance and are often utilized for lower-cost blood collection solutions. Although they may not provide the same level of performance as PVC or TPU, their affordability makes them an attractive option for smaller healthcare facilities or in regions where cost constraints are a significant concern. As healthcare providers explore budget-friendly alternatives, the demand for PE blood bags is expected to see gradual growth within the market.

Others:

The 'Others' category for material types encompasses various alternative materials that may be utilized for disposable plastic blood bags, including bio-based or biodegradable plastics. As sustainability becomes a critical focus in healthcare, there is a growing interest in exploring materials that minimize environmental impact. These alternative materials may offer similar performance characteristics while being more environmentally friendly. While currently a small segment of the market, innovations in material science may pave the way for broader adoption of these alternatives, reflecting the industry's shift towards sustainability and responsible practices.

By Region

The North American region dominates the disposable plastic blood bag market owing to the presence of advanced healthcare infrastructure, high blood donation rates, and stringent regulations regarding blood safety. The United States, in particular, is a significant contributor to this market, fueled by the increasing demand for blood transfusion services and a robust network of blood banks and hospitals. The region is expected to maintain a steady growth rate of approximately 6.0% CAGR during the forecast period. Additionally, advancements in blood management technologies and high healthcare expenditure are driving the demand for disposable plastic blood bags in North America, reinforcing its market dominance.

In Europe, the disposable plastic blood bag market is also witnessing substantial growth, with a projected CAGR of 5.5% over the forecast period. The rise in chronic diseases, an aging population, and an increasing number of surgical procedures are driving the demand for blood transfusions in the region. Countries like Germany, France, and the UK are leading in terms of blood donation initiatives and healthcare infrastructure, which further supports market growth. The European market is characterized by high standards of blood safety and quality, prompting healthcare facilities to rely on disposable plastic blood bags for their transfusion needs.

Opportunities

There are significant opportunities for growth in the disposable plastic blood bag market, primarily driven by advancements in technology and increasing awareness regarding blood safety. The introduction of innovative blood bag designs, incorporating features such as anti-coagulation and filtration systems, presents manufacturers with an avenue to enhance their product offerings. Moreover, the trend toward personalized medicine has led to an increased demand for blood component therapies, further boosting the need for efficient blood management solutions. As healthcare providers globally prioritize improvements in patient care and outcomes, the demand for high-quality disposable blood bags is projected to rise. Collaborations between blood bag manufacturers and healthcare facilities can also drive growth by ensuring that products meet the exacting standards required for safe blood storage and transfusion.

The expanding healthcare infrastructure in emerging markets presents another significant opportunity for the disposable plastic blood bag market. As countries like India, China, and Brazil invest in improving their healthcare systems, the demand for safe and effective blood transfusion services is expected to increase substantially. The rise in disposable income and growing awareness regarding the importance of blood donation will likely drive blood donation initiatives, further enhancing the demand for disposable plastic blood bags. Manufacturers that can establish a presence in these markets and adapt their products to meet local needs can capitalize on this growth potential, tapping into a burgeoning customer base keen on improving healthcare outcomes.

Threats

Despite the promising growth prospects in the disposable plastic blood bag market, several threats could pose challenges to industry players. One significant concern is the increasing competition from alternative technologies and materials that seek to replace traditional plastic blood bags. Innovations in blood storage solutions, such as blood storage systems utilizing advanced monitoring technologies, may reduce reliance on disposable plastic bags, potentially impacting market demand. Additionally, the ongoing debate regarding environmental sustainability and the environmental impact of plastic waste may lead to increased regulatory scrutiny, which could create barriers for manufacturers in the future. The necessity for compliance with evolving environmental regulations may compel companies to invest in costly adaptations or face penalties, affecting overall profitability.

Another potential threat to the disposable plastic blood bag market is the volatility of raw material prices. Fluctuations in the availability and cost of materials such as PVC, TPU, and PET may lead to increased production costs for manufacturers. This could result in higher prices for end-users, ultimately affecting demand. Furthermore, businesses in the sector must also consider the potential impact of global economic conditions, such as recessions or instability, which could lead to reduced healthcare spending and affect the overall market landscape. Companies must remain vigilant and responsive to these threats to ensure sustained growth and market resilience.

Competitor Outlook

• Terumo Corporation
• Grifols S.A.
• Haemonetics Corporation
• Macopharma
• Fresenius SE & Co. KGaA
• Blood Systems, Inc.
• Glenveigh Medical
• Medline Industries, Inc.
• HemoCue AB
• Biolife Plasma Services
• Baxter International Inc.
• Cardinal Health, Inc.
• JMS Co., Ltd.
• Sangui BioTech International, Inc.
• Beckton Dickinson and Company

The competitive landscape of the disposable plastic blood bag market is characterized by a mix of established players and emerging companies aiming to capture market share through innovation and strategic partnerships. Major companies are investing significantly in research and development to create advanced blood bag technologies that offer enhanced safety, sterility, and efficiency. Innovations such as integrated monitoring systems that provide real-time data on blood storage conditions are gaining traction among healthcare providers, prompting manufacturers to differentiate their offerings. The emphasis on product quality and compliance with stringent regulatory requirements further intensifies competition, as companies strive to meet the high standards demanded by hospitals and blood banks.

Among the key players, Terumo Corporation is recognized for its innovative blood management solutions, including disposable plastic blood bags with advanced features for component separation. Their commitment to research and development has positioned them as a leader in the market. Similarly, Grifols S.A., known for its expertise in blood plasma products, is also making inroads into the disposable blood bag segment by providing customized solutions that meet the diverse needs of healthcare facilities. Their extensive distribution network and strong brand reputation further bolster their competitive standing.

Additionally, Haemonetics Corporation has established itself as a prominent player by focusing on blood management systems that enhance the efficiency of blood collection and storage. Their commitment to delivering high-quality products and exceptional customer service has earned them a loyal client base in the healthcare sector. Other companies, such as Fresenius SE & Co. KGaA and Baxter International Inc., are also making strides in the disposable plastic blood bag market by leveraging their extensive expertise in medical products and technologies. These companies are anticipated to play a vital role in shaping the future of the market through continued innovation and partnerships.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 HemoCue AB
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Macopharma
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Grifols S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 JMS Co., Ltd.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Glenveigh Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Terumo Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Blood Systems, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Cardinal Health, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Biolife Plasma Services
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Fresenius SE & Co. KGaA
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Haemonetics Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Medline Industries, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Baxter International Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Beckton Dickinson and Company
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Sangui BioTech International, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Disposable Plastic Blood Bag Sales Market, By Application
    • 6.1.1 Blood Banks
    • 6.1.2 Hospitals
    • 6.1.3 Clinics
    • 6.1.4 Others
  • 6.2 Disposable Plastic Blood Bag Sales Market, By Product Type
    • 6.2.1 Single Blood Bag
    • 6.2.2 Double Blood Bag
    • 6.2.3 Triple Blood Bag
    • 6.2.4 Quadruple Blood Bag
    • 6.2.5 Penta Blood Bag
  • 6.3 Disposable Plastic Blood Bag Sales Market, By Distribution Channel
    • 6.3.1 Online Stores
    • 6.3.2 Hospitals & Clinics
    • 6.3.3 Blood Donation Centers
    • 6.3.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Disposable Plastic Blood Bag Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Disposable Plastic Blood Bag Sales market is categorized based on

By Product Type

• Single Blood Bag
• Double Blood Bag
• Triple Blood Bag
• Quadruple Blood Bag
• Penta Blood Bag

By Application

• Blood Banks
• Hospitals
• Clinics
• Others

By Distribution Channel

• Online Stores
• Hospitals & Clinics
• Blood Donation Centers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Terumo Corporation
• Grifols S.A.
• Haemonetics Corporation
• Macopharma
• Fresenius SE & Co. KGaA
• Blood Systems, Inc.
• Glenveigh Medical
• Medline Industries, Inc.
• HemoCue AB
• Biolife Plasma Services
• Baxter International Inc.
• Cardinal Health, Inc.
• JMS Co., Ltd.
• Sangui BioTech International, Inc.
• Beckton Dickinson and Company